Skip to main content
Log in

Physostigmine alters onset but not duration of REM sleep in man

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Physostigmine (1.0 mg) or placebo were administered intravenously over 1-h period to seven male normal volunteers beginning 35 min after sleep onset. The results indicate that physostigmine induced the onset of REM sleep but did not significantly alter the duration of individual REM sleep periods. Physostigmine significantly shortened the REM latency and the duration of the second non REM period. After inducing the onset of the first REM period(s), physostigmine also appeared to advance succeeding REM-nonREM sleep cycles relative to sleep onset even when the duration of each cycle was unaffected.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Agnew, H. W., Webb, W. B., Williams, R. L.: Comparison of stage four and 1-REM deprivation. Percept, Mot. Skills 24, 851–858 (1967)

    Google Scholar 

  • Amatruda, T. T., Black, D. A., McKenna, T. M., McCarley, R. W., Hobson, J. A.: Sleep cycle control and cholinergic mechanisms: differential effecgs of carbachol at pontine brain stem sites. Brain Res. 98, 501–505 (1975)

    Google Scholar 

  • George, R., Haslett, W. L., Jenden, D. J.: A cholinergic mechanism in the brain stem reticular formation: induction of paradoxical sleep. Int. J. Neuropharmacol. 3, 541–552 (1964)

    Google Scholar 

  • Gillin, J. C., Mendelson, W. B., Sitaram, N., Wyatt, R. J.: The neuropharmacology of sleep and wakefulness. Annu. Rev. Pharmacol. Toxicol. (in press, 1978)

  • Hobson, J. A., McCarley, R. W., McKenua, T. M.: Cellular evidence bearing on the pontine brain stem hypothesis of desynchronized sleep control. Prog. Neurociol. 6, 155–376 (1976)

    Google Scholar 

  • Jouvet, M.: Cholinergic mechanisms and sleep. In: Cholinergic mechanisms, P. G. Waser, ed., pp. 455–476. New York: Raven 1975

    Google Scholar 

  • Jouvet, M.: Recherches sur les structures nerveuses et les mecanismes responsables des differentes phases du sommeil physiologique. Arch. Ital. Biol. 100, 125–206 (1962)

    Google Scholar 

  • Karczmar, A. G., Longo, V. G., Scott de Carolis, A.: A pharmacological model of paradoxical sleep: the role of cholinergic and monoamine systems. Physiol. Behav. 5, 175–182 (1970)

    Google Scholar 

  • Mitler, M. M., Dement, W. C.: Cataplectic-like behavior in cats after microinjection of carbachol in pontine reticular formation. Brain Res. 68, 335–343 (1974)

    Google Scholar 

  • Rechtschaffen, A., Kales, A.: A manual of standard techniques and scoring system for sleep states of human subjects. NIH Publication No. 204, Bethesda, Maryland 1968

  • Sitaram, N., Mendelson, W. B., Wyatt, R. J., Gillin, J. C.: The time-dependent induction of REM sleep and arousal by physostigmine infusion during normal human sleep. Brain Res. 122, 562–567 (1977)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gillin, J.C., Sitaram, N., Mendelson, W.B. et al. Physostigmine alters onset but not duration of REM sleep in man. Psychopharmacology 58, 111–114 (1978). https://doi.org/10.1007/BF00426799

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00426799

Key words

Navigation